139 related articles for article (PubMed ID: 5711258)
41. [Central and peripheral secondary effects of some butyrophenones].
Salvini L; Frosali L; Gigli M
Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993
[No Abstract] [Full Text] [Related]
42. Drug therapy.
Stone WN; Hofling CK; Winslow WW
Prog Neurol Psychiatry; 1968; 23():563-81. PubMed ID: 4890081
[No Abstract] [Full Text] [Related]
43. [Buronil in senile confusion and excitement. A double-blind study].
Norgård A; Tingsgaard P; Nielsen IL
Nord Psykiatr Tidsskr; 1967; 21(3):240-4. PubMed ID: 4871566
[No Abstract] [Full Text] [Related]
44. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
Svestka J; Náhunek K
Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
[No Abstract] [Full Text] [Related]
45. [The blood pressure lowering effect of chlorpromazine and methylperon (Buronil)].
Magner O; Moller S
Ugeskr Laeger; 1974 Apr; 136(15):809-11. PubMed ID: 4597391
[No Abstract] [Full Text] [Related]
46. [Buronil and promazine therapy of patients with senile dementia. A double-blind study].
Engstrand E
Nord Psykiatr Tidsskr; 1967; 21(3):234-40. PubMed ID: 4871565
[No Abstract] [Full Text] [Related]
47. [Side effects of methylperone in long-term therapy up to 8 years].
Kirkegaard G; Kirkegaard A
Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
[No Abstract] [Full Text] [Related]
48. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
Van Renynghe de Voxvrie G; De Bie M
Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
[TBL] [Abstract][Full Text] [Related]
49. [Palatoschisis induced by trifluperidol in mice].
Vichi F; Pierleoni P; Orlando S; Tollaro I
Sperimentale; 1968; 118(4):245-51. PubMed ID: 5740872
[No Abstract] [Full Text] [Related]
50. [Clinical report on a high potency neuroleptic agent with certain specific 24-hour-effect after oral administration].
Zick WH
Med Welt; 1969 Jul; 30():1659-61. PubMed ID: 5355657
[No Abstract] [Full Text] [Related]
51. [Morphological aspects of the association of triperidol and thioridazine. (Histological experimental study)].
Pastena L; Ranzato FP
Riv Neurobiol; 1968; 14(4):632-43. PubMed ID: 5738412
[No Abstract] [Full Text] [Related]
52. [The customary drugs in the therapy of mental illness in France].
Ginestet D; Deniker P
Nervenarzt; 1967 Sep; 38(9):400-3. PubMed ID: 6052766
[No Abstract] [Full Text] [Related]
53. Effects of haloperidol and trifluperidol on operant behavior in the rat.
Monti JM; Hance AJ
Psychopharmacologia; 1967; 12(1):34-43. PubMed ID: 6081326
[No Abstract] [Full Text] [Related]
54. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
Niemegeers CJ; Verbruggen FJ; Janssen PA
Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
[No Abstract] [Full Text] [Related]
55. [Buronil, a new butyrophenone derivative for acute psychiatric disorders. A comparison with chlorpromazine and chlorprothixene].
Haugen T
Ugeskr Laeger; 1967 Sep; 129(37):1194-7. PubMed ID: 5584977
[No Abstract] [Full Text] [Related]
56. [Effect of triperidol on glucose and pyruvic acid metabolism in rat cerebral cortex slices].
Gatti G; Michalek H; Pocchiari F
Ann Ist Super Sanita; 1966; 2(2):277-86. PubMed ID: 6005037
[No Abstract] [Full Text] [Related]
57. [Clinical trial of a new psychopharmacological agent: piperonyl].
Gazzaniga GC; Terzi GF
Riv Sper Freniatr Med Leg Alien Ment; 1971 Aug; 95(4):799-807. PubMed ID: 5114798
[No Abstract] [Full Text] [Related]
58. [Therapeutic effect of triperidol].
Cwynar S; Pionkowski J; Tomczak W; Tyszka E
Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
[No Abstract] [Full Text] [Related]
59. TRIFLUPERIDOL: A BUTYROPHENONE DERIVATIVE.
GALLANT DM; BISHOP MP; TIMMONS E; STEELE CA
Am J Psychiatry; 1963 Nov; 120():485-7. PubMed ID: 14051242
[No Abstract] [Full Text] [Related]
60. factors influencing response to major tranquilizer medications.
Kimbell I; Overall JE; Faibish GM; Pokorny AD
Dis Nerv Syst; 1972 Apr; 33(4):223-30. PubMed ID: 5029910
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
